Last reviewed · How we verify

NCT03167333

The Role of Synovitis in Osteoarthritis

Status unknown NA Last updated 11 February 2020
What this trial tests

NA trial testing platelet rich plasma in Synovitis of Knee in 100 participants. Status unknown.

Timeline
1 March 2020
Primary endpoint
1 March 2020
1 March 2020

Quick facts

Lead sponsorTaipei Veterans General Hospital, Taiwan
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment100
Start date1 March 2020
Primary completion1 March 2020
Estimated completion1 March 2020
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

Taipei Veterans General Hospital, Taiwan

Who can join

Adults 45 to 75, any sex, with Synovitis of Knee or Osteoarthritis, Knee. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To determine whether platelet-rich-plasma (PRP) or HA (hyaluronic acid)injection into synovitis in osteoarthritis(OA) knee can achieve improvement in knee function and reduce synovitis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of platelet rich plasma

Trials testing the same drug.

Other recruiting trials for Synovitis of Knee

Currently open trials in the same condition.

Other Taipei Veterans General Hospital, Taiwan trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03167333.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing